Your browser doesn't support javascript.
loading
Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer.
Mahajan, Abhishek; Goyal, Devendra; Agarwal, Ujjwal; Patil, Vijay; Shukla, Shreya; Noronha, Vanita; Joshi, Amit; Menon, Nandini; Prabhash, Kumar.
Affiliation
  • Mahajan A; Clatterbridge Centre for Oncology NHS Foundation Trust, L7 8YA Liverpool, UK.
  • Goyal D; Department of Radiodiagnosis, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
  • Agarwal U; Department of Radiodiagnosis, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
  • Patil V; Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
  • Shukla S; Department of Radiodiagnosis, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
  • Noronha V; Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
  • Joshi A; Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
  • Menon N; Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
  • Prabhash K; Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai 400012, Maharashtra, India.
Explor Target Antitumor Ther ; 4(5): 896-911, 2023.
Article in En | MEDLINE | ID: mdl-37970209
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Explor Target Antitumor Ther Year: 2023 Document type: Article Affiliation country: United kingdom Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Explor Target Antitumor Ther Year: 2023 Document type: Article Affiliation country: United kingdom Country of publication: United States